https://www.ibtomato.com/ExternalView.aspx?type=1&no=19372IB토마토ko2026-08-28T16:49:33+09:00(공시톺아보기)감자라고 다 같은 감자 아니다…인적분할 땐 왜https://www.ibtomato.com/ExternalView.aspx?type=1&no=19369IB토마토ko2026-08-28T15:36:47+09:00(IPO인사이트)래블업, 삼성전자도 쓰는 AI 인프라…코스닥 도전https://www.ibtomato.com/ExternalView.aspx?type=1&no=19368IB토마토ko2026-08-28T15:31:18+09:00(크레딧시그널)코웨이, 해외 성장 '탄탄'…늘어난 차입도 관리권https://www.ibtomato.com/ExternalView.aspx?type=1&no=19334IB토마토ko2026-08-26T16:47:11+09:00(총수의 베팅)①책임투자냐 '기회의 사유화'냐…이해상충 논란https://www.ibtomato.com/ExternalView.aspx?type=1&no=19331IB토마토ko2026-08-26T17:53:17+09:00카카오뱅크, 광고수익 81% 성장…대주주 거래가 한몫https://www.ibtomato.com/ExternalView.aspx?type=1&no=19326IB토마토ko2026-08-26T15:59:09+09:00깨끗한나라, 적자·유동성·주가 '삼중고'…최현수 대표 첫 시험대https://www.ibtomato.com/ExternalView.aspx?type=1&no=19332IB토마토ko2026-08-26T11:00:02+09:00삼표 성수개발, 착공 전인데 5200억 만기…금융비용 압박https://www.ibtomato.com/ExternalView.aspx?type=1&no=19358IB토마토ko2026-08-27T18:41:59+09:00HLB이노베이션, 적자 속 적자 자회사 인수…계열사 위험 떠안았나https://www.ibtomato.com/ExternalView.aspx?type=1&no=19329IB토마토ko2026-08-26T10:54:51+09:00이연제약, 파이프라인 세대교체…흑자 전환 '고삐'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19341IB토마토ko2026-08-26T17:36:39+09:00LG, 자사주 다 태우고 또 산다…주주환원 확대 시동https://www.ibtomato.com/ExternalView.aspx?type=1&no=19327IB토마토ko2026-08-26T10:14:24+09:00한화솔루션, 차입 줄이려 '알짜 지분' 매각…재무개선 한계는 여전https://www.ibtomato.com/ExternalView.aspx?type=1&no=19330IB토마토ko2026-08-25T18:05:52+09:005세대 실손 확대 본격화…보험사 손해율 개선은 2030년부터https://www.ibtomato.com/ExternalView.aspx?type=1&no=19354IB토마토ko2026-08-27T21:05:00+09:00(경제TOP아보기)30만명 온다는데…송도 F1은 왜 멈췄나https://www.ibtomato.com/ExternalView.aspx?type=1&no=19355IB토마토ko2026-08-27T17:38:53+09:00(Deal모니터)한화리츠, 2000억 차환…만기 연장에 금리 부담https://www.ibtomato.com/ExternalView.aspx?type=1&no=19351IB토마토ko2026-08-27T11:06:45+09:00(크레딧시그널)DB캐피탈, 대손비용 확대에 수익성 '뒷걸음'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19353IB토마토ko2026-08-27T11:05:27+09:00(Deal클립)교보생명, 5000억 자본확충에도 기본자본 K-ICS는 하락